6ER-010 Therapeutic drug monitoring of tumour necrosis factor α inhibitors in inflammatory bowel disease: evidence from a real world setting

Autor: A Loba, Valeska Andreozzi, M. Capoulas, M Vargas Gomes, Alison Wagner Azevedo Barroso, Jorge Félix, Cecília R.A. Santos

Publikováno v: Section 6: Education and Research.

Background and importance Biologics have become the mainstay for treatment of inflammatory bowel disease (IBD) but these drugs often require dose escalation to maintain effectiveness. Currently, therapeutic drug monitoring (TDM) can be used to measur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d417f3f9c8d360bf90cf62f32b7790f
https://doi.org/10.1136/ejhpharm-2020-eahpconf.445

6ER-012 Persistence for disease modifying drugs for multiple sclerosis

Autor: Valeska Andreozzi, Magda Rodrigues, Ana Luiza Gonçalves Soares, M Vargas Gomes, A Alcobia, Pedro Almeida, Jorge Félix

Publikováno v: Section 6: Education and Research.

Background and importance Persistence of therapy is fundamental to achieve disease management goals. Due to the chronic nature of multiple sclerosis treatment, interventions by hospital pharmacists is fundamental to patient persistence with disease m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2a2e862e7e9a6b00dd1f9ae3a50548a
https://doi.org/10.1136/ejhpharm-2020-eahpconf.447

5PSQ-016 Unfavourable outcomes of blood transfusions in hospitalised anaemic patients

Autor: M. Placido, Helena S. Pereira, A Alcobia, Valeska Andreozzi, Marta Afonso-Silva, Sara Rabiais, Ana Luiza Gonçalves Soares, H. Mansinho, M Vargas Gomes, Jorge Félix, M.F. Delerue, M. Amorim

Publikováno v: Section 5: Patient Safety and Quality Assurance.

Background Guidelines recommend the administration of intravenous (IV) iron to patients with anaemia due to iron deficiency. Blood transfusions are the last resource, advised only in critical patients, as they quickly raise haemoglobin (Hb) levels. H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fd83b7d0c3fe6fe19eff4e672949b86
https://doi.org/10.1136/ejhpharm-2019-eahpconf.449

Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study).

Autor: Silva R; Paediatrics Department, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal., Guerra P; Paediatrics Department, Centro Hospitalar Universitário de São João, Porto, Portugal., Rocha A; Surgery Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal., Correia M; Paediatrics Department, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal., Ferreira R; Paediatrics Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal., Fonseca J; Gastroenterology Department, Hospital Garcia de Orta, Lisboa, Portugal., Lima E; Surgery Department, Centro Hospitalar Universitário de São João, Porto, Portugal., Oliveira A; Surgery Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal., Vargas Gomes M; Exigo Consultores, Lisboa, Portugal., Ramos D; Exigo Consultores, Lisboa, Portugal., Andreozzi V; Exigo Consultores, Lisboa, Portugal., Santos MD; Surgery Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal.

Publikováno v: GE Portuguese journal of gastroenterology [GE Port J Gastroenterol] 2022 Sep 08; Vol. 30 (4), pp. 293-304. Date of Electronic Publication: 2022 Sep 08 (Print Publication: 2023).